Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells

No abstract is available for this paper.

• Publication year

  2017

• Venue

  JBIC Journal of Biological Inorganic Chemistry

• Publication date

  2017-05-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00775-017-1467-yPMID 28516214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changes in blood concentrations of trace metals in cancer patients receiving cisplatin-based chemotherapy.

  2016cited by this paper
• A ratiometric fluorescent sensor for the mitochondrial copper pool.

  2016cited by this paper
• Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity.

  2016cited by this paper
• The Intestinal Copper Exporter CUA-1 Is Required for Systemic Copper Homeostasis in Caenorhabditis elegans*♦

  2016cited by this paper
• Recognition- and Reactivity-Based Fluorescent Probes for Studying Transition Metal Signaling in Living Systems

  2015cited by this paper
• Cisplatin inhibits MEK1/2

  2015cited by this paper
• Copper uptake by DMT1: a compensatory mechanism for CTR1 deficiency in human umbilical vein endothelial cells.

  2015cited by this paper
• EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer

  2015cited by this paper
• What has fluorescent sensing told us about copper and brain malfunction?

  2015cited by this paper
• Targeting copper in cancer therapy: 'Copper That Cancer'.

  2015cited by this paper
• Imaging metals in biology: balancing sensitivity, selectivity and spatial resolution.

  2015cited by this paper
• Copper is an endogenous modulator of neural circuit spontaneous activity

  2014cited by this paper
• Cisplatin binds to human copper chaperone Cox17: the mechanistic implication of drug delivery to mitochondria.

  2014cited by this paper
• Structural biology of cisplatin complexes with cellular targets: the adduct with human copper chaperone atox1 in aqueous solution.

  2014cited by this paper
• Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cells.

  2013cited by this paper
• Zinc supplementation does not alter sensitive biomarkers of copper status in healthy boys.

  2013cited by this paper
• A Re-Evaluation of the Role of hCTR1, the Human High-Affinity Copper Transporter, in Platinum-Drug Entry into Human Cells

  2013cited by this paper
• Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals

  2013cited by this paper
• Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells.

  2012cited by this paper
• Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy.

  2012cited by this paper
• Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy.

  2011cited by this paper
• Probing the interaction of cisplatin with the human copper chaperone Atox1 by solution and in-cell NMR spectroscopy.

  2011cited by this paper
• The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin.

  2010cited by this paper
• Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator.

  2010cited by this paper
• Role of the Copper Transporter, CTR1, in Platinum-Induced Ototoxicity

  2010cited by this paper
• The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity.

  2009cited by this paper
• The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs

  2009cited by this paper
• Biomarkers of copper status: a brief update.

  2008cited by this paper
• The resurgence of platinum-based cancer chemotherapy

  2007cited by this paper
• Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells.

  2007cited by this paper
• Distinct Mechanisms for Ctr1-mediated Copper and Cisplatin Transport*

  2007cited by this paper
• Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.

  2004cited by this paper
• Cisplatin Stabilizes a Multimeric Complex of the Human Ctr1 Copper Transporter

  2004cited by this paper
• The Copper Influx Transporter Human Copper Transport Protein 1 Regulates the Uptake of Cisplatin in Human Ovarian Carcinoma Cells

  2004cited by this paper
• Cisplatin Rapidly Down-regulates Its Own Influx Transporter hCTR1 in Cultured Human Ovarian Carcinoma Cells

  2004cited by this paper
• Cu, Zn-Superoxide Dismutase is Lower and Copper Chaperone CCS is Higher in Erythrocytes of Copper-Deficient Rats and Mice

  2004cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• Copper-stimulated Endocytosis and Degradation of the Human Copper Transporter, hCtr1*

  2003cited by this paper
• Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals

  2002cited by this paper
• Is cisplatin-induced cell death always produced by apoptosis?

  2001cited by this paper
• The Copper Chaperone CCS Directly Interacts with Copper/Zinc Superoxide Dismutase*

  1998cited by this paper

• Host Defense Peptide Mimics Synergize with Pt(IV) Prodrugs for Surmounting Cisplatin Resistance via Selective Cancer Membrane Disruption.

  2025cites this paper
• Integrative Metabolomics and Ionomics Identify Organ-Specific Responses Associated with Cisplatin Treatment in Mice

  2025cites this paper
• Polyphyllin VII Enhances the Antitumor Activity of Cisplatin in Non‐Small Cell Lung Cancer Cells by Inducing Ferroptosis and Enhancing Apoptosis

  2025cites this paper
• Small-Molecule Fluorescent Probes for Binding- and Activity-Based Sensing of Redox-Active Biological Metals.

  2024cites this paper
• Integrative Co-Registration of Elemental Imaging and Histopathology for Enhanced Spatial Multimodal Analysis of Tissue Sections through TRACE

  2024cites this paper
• Genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer

  2024cites this paper
• Recent Development on Copper-Sensor and its Biological Applications: A Review

  2024cites this paper
• Exploring Copper’s role in stroke: progress and treatment approaches

  2024cites this paper
• Improved efficacy of cisplatin delivery by peanut agglutinin-modified liposomes in non-small cell lung cancer

  2024cites this paper
• In vitro and in vivo accumulation of the anticancer Ru complexes [Ru^II(cym)(HQ)Cl] and [Ru^II(cym)(PCA)Cl]Cl

  2023cites this paper
• A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response

  2023cites this paper
• Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma

  2023cites this paper
• Effect of Polymorphisms in Drug Transporters on Cisplatin Efficacy and Nephrotoxicity in Paediatric Osteosarcoma

  2022cites this paper
• Investigations of cellular copper metabolism in ovarian cancer cells using a ratiometric fluorescent copper dye

  2022cites this paper
• Recent Advances in Copper-Based Organic Complexes and Nanoparticles for Tumor Theranostics

  2022cites this paper
• Glucose restriction induces ROS-AMPK-mediated CTR1 expression and increases cisplatin efficiency in NSCLC.

  2022cites this paper
• Emerging roles of the copper-CTR1 axis in tumorigenesis.

  2022cites this paper
• A caged imidazopyrazinone for selective bioluminescence detection of labile extracellular copper(ii)

  2022cites this paper
• Perftoran ® Inhibits Hypoxia-Associated Resistance in Lung Cancer Cells to Carboplatin

  2022cites this paper
• Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases

  2022cites this paper
• Copper in tumors and the use of copper-based compounds in cancer treatment.

  2021cites this paper
• Pathogenesis and therapeutic strategy in platinum resistance lung cancer.

  2021cites this paper
• The Effects on Angiogenesis of Relevant Inorganic Chemotherapeutics.

  2020cites this paper
• Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment

  2020cites this paper
• ATPase copper transporter A, negatively regulated by miR‐148a‐3p, contributes to cisplatin resistance in breast cancer cells

  2020cites this paper
• PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1

  2020cites this paper
• The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents

  2020cites this paper
• Synergistic platinum (II) prodrug nanoparticle for enhanced breast cancer therapy.

  2020cites this paper
• Platinum(IV) antitumor complexes and their nano-drug delivery

  2020cites this paper
• The asymmetry of plasma membranes and their cholesterol content influence the uptake of cisplatin

  2019cites this paper
• Mice with a Sertoli cell-specific knockout of the Ctr1 gene exhibit a reduced sensitivity to cisplatin-induced testicular germ cell apoptosis

  2019cites this paper
• Fate of cisplatin and its main hydrolysed forms in the presence of thiolates: a comprehensive computational and experimental study.

  2019cites this paper
• Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies

  2019cites this paper
• Element 78 – Platinum

  2019cites this paper
• Mechanistic and structural basis for inhibition of copper trafficking by platinum anticancer drugs.

  2019cites this paper
• Silver Ions as a Tool for Understanding Different Aspects of Copper Metabolism

  2019cites this paper
• May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?

  2019cites this paper
• Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation

  2018cites this paper
• Interactions of Schiff base compounds and their coordination complexes with the drug cisplatin

  2018cites this paper
• Permeation of cisplatin through the membranes of normal and cancer cells: a molecular dynamics study

  2018influential citation
• Curcumin enhances cisplatin sensitivity of human NSCLC cell lines through influencing Cu-Sp1-CTR1 regulatory loop.

  2018cites this paper
• The influence of the ethane-1,2-diamine ligand on the activity of a monofunctional platinum complex.

  2017cites this paper